— Know what they know.
Not Investment Advice

AJANTPHARM.BO

Ajanta Pharma Limited
1W: -4.7% 1M: -1.9% 3M: +12.2% YTD: -0.5% 1Y: +4.1% 3Y: +150.5% 5Y: +157.0%
₹2,879.65 ($30.56)
+17.15 (+0.60%)
 
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ₹359.8B · Alpha Radar Buy · Power 53
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹359.8B ($3.8B)
52W Range2022.05-3020.45
Volume1,583
Avg Volume7,658
Beta0.16
Dividend₹28.00
Analyst Ratings
No analyst coverage
Company Info
CEOYogesh Mannalal Agrawal
Employees8,073
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2002-07-01
Ajanta House
Mumbai 400067
IN
91 22 6606 1000
About Ajanta Pharma Limited

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as antimalarial, cardiology, ophthalmology, dermatology, pain management, gastroenterology, antihistamine, respiratory, diabetes areas. It also provides tablets, capsules, powder, liquid, jelly, ointments, sterile eye drops, active pharma ingredient. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms